Drug Type ASO |
Synonyms- |
Target |
Action modulators, inhibitors |
Mechanism MPPE1 modulators(metallophosphoesterase 1 modulators), RBBP4 inhibitors(RB binding protein 4, chromatin remodeling factor inhibitors) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Hepatitis | Discovery | - | 02 Jan 2026 | |
| Neoplasms | Discovery | - | 02 Jan 2026 |





